| Not Yet Recruiting | A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Mult NCT07319897 | Peking University First Hospital | Phase 2 / Phase 3 |
| Completed | Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell NCT00448201 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Terminated | Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodyspl NCT01118013 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00568880 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Terminated | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Underg NCT01116232 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Completed | Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Canc NCT01164709 | Swiss Cancer Institute | Phase 1 |
| Terminated | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Canc NCT00946283 | Rutgers, The State University of New Jersey | N/A |
| Terminated | Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant NCT01077440 | Vanderbilt University | — |
| Terminated | Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smolderi NCT00942422 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Completed | Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma NCT00938626 | Barbara Ann Karmanos Cancer Institute | Phase 1 |
| Terminated | Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation NCT00996359 | University of Medicine and Dentistry of New Jersey | Phase 1 |
| Recruiting | Registry of Older Patients With Cancer NCT01137825 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer NCT00935090 | Barbara Ann Karmanos Cancer Institute | — |
| Completed | Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma NCT00962507 | City of Hope Medical Center | Phase 1 |
| Recruiting | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643 | UNC Lineberger Comprehensive Cancer Center | — |
| Completed | Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma NCT00941720 | Case Comprehensive Cancer Center | Phase 2 |
| Terminated | Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer NCT00726830 | M.D. Anderson Cancer Center | N/A |
| Completed | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer NCT00823524 | Asan Medical Center | Phase 1 / Phase 2 |
| Completed | Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone NCT00993694 | Vanderbilt University | — |
| Completed | Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma NCT00772915 | Mayo Clinic | Phase 2 |
| Terminated | Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transpla NCT00800150 | City of Hope Medical Center | Phase 1 |
| Terminated | Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunte NCT00952185 | City of Hope Medical Center | N/A |
| Completed | American Ginseng in Treating Patients With Fatigue Caused by Cancer NCT00719563 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractor NCT00744354 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Completed | Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor NCT00755040 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Terminated | Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00687674 | Mayo Clinic | Phase 1 |
| Terminated | Blood Samples From Patients on a Clinical Trial to CINV During HSCT NCT00900068 | OHSU Knight Cancer Institute | — |
| Completed | Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide NCT00899080 | Eastern Cooperative Oncology Group | — |
| Unknown | Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Mu NCT00742404 | Oncotherapeutics | Phase 2 |
| Terminated | Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Ce NCT00725062 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Terminated | Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transpla NCT00813501 | City of Hope Medical Center | — |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hem NCT00691015 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Withdrawn | Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers NCT00770419 | Rutgers, The State University of New Jersey | — |
| Terminated | Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma NCT00635024 | Mayo Clinic | Phase 2 |
| Terminated | Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma NCT00897910 | Barbara Ann Karmanos Cancer Institute | — |
| Unknown | High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With R NCT00747877 | Leeds Cancer Centre at St. James's University Hospital | Phase 3 |
| Completed | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clin NCT00750009 | Case Comprehensive Cancer Center | Phase 3 |
| Terminated | Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Canc NCT00918658 | Case Comprehensive Cancer Center | — |
| Completed | Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in NCT00516503 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With NCT00792142 | City of Hope Medical Center | Phase 2 |
| Completed | Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Under NCT00513474 | Massachusetts General Hospital | Phase 1 |
| Unknown | Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders NCT00740467 | Institut Paoli-Calmettes | Phase 2 |
| Completed | Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma NCT00569309 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis NCT00564889 | Mayo Clinic | Phase 2 |
| Terminated | High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myelom NCT00637767 | University of Southampton | Phase 2 |
| Completed | Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma NCT00566098 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 / Phase 2 |
| Terminated | Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma NCT00567229 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis NCT00558896 | Mayo Clinic | Phase 2 |
| Terminated | Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma NCT00470093 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | EARLY_Phase 1 |
| Terminated | Studying Fentanyl in Patients With Cancer NCT00899951 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma NCT00474929 | Mayo Clinic | Phase 1 / Phase 2 |
| Terminated | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant NCT00602446 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Withdrawn | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer NCT00499668 | Vanderbilt-Ingram Cancer Center | N/A |
| Terminated | Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose M NCT00602147 | Vanderbilt-Ingram Cancer Center | — |
| Withdrawn | Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant NCT00504101 | University of Miami | Phase 1 |
| Completed | Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers NCT00619645 | University of California, Davis | Phase 2 |
| Completed | Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy NCT00416624 | Mayo Clinic | Phase 2 |
| Terminated | Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating NCT00376519 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoi NCT00589563 | City of Hope Medical Center | Phase 2 |
| Terminated | Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Ac NCT00469820 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multip NCT00802568 | Institut Paoli-Calmettes | Phase 2 |
| Completed | Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Tr NCT00787761 | Northside Hospital, Inc. | Phase 2 |
| Completed | Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Pa NCT00806767 | Institut Paoli-Calmettes | Phase 2 |
| Completed | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases NCT00453206 | Wake Forest University Health Sciences | N/A |
| Completed | Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients Wi NCT00458822 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant NCT00900406 | Vanderbilt-Ingram Cancer Center | — |
| Completed | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases NCT00424242 | Northwestern University | EARLY_Phase 1 |
| Completed | Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Ce NCT00964821 | City of Hope Medical Center | — |
| Completed | Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00445484 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Unknown | Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer NCT00482716 | St. Bartholomew's Hospital | Phase 3 |
| No Longer Available | Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease NCT00423826 | Barbara Ann Karmanos Cancer Institute | — |
| Completed | Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory M NCT00499577 | University of Maryland Greenebaum Cancer Center | Phase 1 / Phase 2 |
| Terminated | T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant NCT00651716 | Vanderbilt-Ingram Cancer Center | — |
| Completed | Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma NCT00609167 | Mayo Clinic | Phase 2 |
| Completed | Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone Wi NCT00458705 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previo NCT00438841 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Study of DNA Samples From Patients With Multiple Myeloma NCT00898040 | ECOG-ACRIN Cancer Research Group | — |
| Completed | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Ha NCT00410657 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma NCT00478218 | Mayo Clinic | Phase 2 |
| Completed | Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or NCT00376922 | Wake Forest University Health Sciences | N/A |
| Completed | Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients Wit NCT00523848 | Roswell Park Cancer Institute | Phase 2 |
| Terminated | Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating P NCT00827099 | Northside Hospital, Inc. | Phase 2 |
| Terminated | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant NCT00324324 | OHSU Knight Cancer Institute | Phase 3 |
| Withdrawn | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose T NCT00085449 | Alliance for Clinical Trials in Oncology | Phase 1 / Phase 2 |
| Completed | Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma NCT00317798 | University of Rochester | Phase 1 |
| Completed | Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00482495 | Mayo Clinic | Phase 2 |
| Completed | Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma NCT00305812 | NCIC Clinical Trials Group | Phase 2 |
| Unknown | Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded NCT00389701 | Sparrow Regional Cancer Center | Phase 2 |
| Completed | Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant NCT00281814 | The Cleveland Clinic | — |
| Unknown | High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, o NCT00526734 | Erasme University Hospital | Phase 2 |
| Completed | Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation NCT00281801 | Case Comprehensive Cancer Center | — |
| Terminated | Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer NCT00281879 | OHSU Knight Cancer Institute | Phase 2 |
| Unknown | Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory NCT00334932 | Herbert Irving Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer NCT00661999 | Mayo Clinic | Phase 3 |
| Completed | Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma NCT00335647 | Immune Control | Phase 1 / Phase 2 |
| Completed | Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00316940 | Oncotherapeutics | Phase 1 |
| Completed | PAD. ICORG 05-01, V11 NCT00814541 | Cancer Trials Ireland | Phase 2 |
| Completed | Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma NCT00378768 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease NCT00719849 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma NCT00317811 | Oncotherapeutics | Phase 2 |
| Completed | Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transp NCT00477971 | Mayo Clinic | Phase 3 |
| Completed | Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen NCT00448357 | UNC Lineberger Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | A Standardized Nursing Intervention Protocol for HCT Patients NCT00951626 | City of Hope Medical Center | N/A |
| Terminated | Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimu NCT00608517 | Vanderbilt-Ingram Cancer Center | N/A |
| Completed | Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Trea NCT00313625 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease NCT00898066 | SWOG Cancer Research Network | — |
| Completed | Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multipl NCT00478075 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer NCT00255749 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Terminated | Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma NCT00258258 | Roswell Park Cancer Institute | Phase 1 |
| Completed | Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem C NCT00288028 | Barbara Ann Karmanos Cancer Institute | Phase 1 |
| Completed | Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic NCT00611351 | University of Nebraska | Phase 2 |
| Completed | Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Tr NCT00245037 | OHSU Knight Cancer Institute | Phase 1 / Phase 2 |
| Completed | Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma NCT00477750 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Tre NCT00477815 | Mayo Clinic | Phase 1 |
| Unknown | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic NCT00295997 | University of California, San Francisco | N/A |
| Completed | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain NCT00666211 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Completed | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patien NCT00258245 | Barbara Ann Karmanos Cancer Institute | Phase 1 |
| Completed | Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With NCT00482378 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00618345 | Mayo Clinic | Phase 2 |
| Completed | Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer NCT00104923 | California Cancer Consortium | Phase 1 |
| Completed | Campath-1H + FK506 and Methylprednisolone for GVHD NCT00109993 | Case Comprehensive Cancer Center | Phase 2 |
| Terminated | Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferativ NCT00176475 | University of Medicine and Dentistry of New Jersey | Phase 1 |
| Completed | Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma NCT00258206 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Be NCT00293384 | Barbara Ann Karmanos Cancer Institute | N/A |
| Completed | Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone NCT00134004 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant NCT00301951 | University of California, San Francisco | Phase 1 |
| Completed | Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple My NCT00054158 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced H NCT00096096 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer NCT00134017 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Terminated | Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refracto NCT00227682 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Pati NCT00084747 | Jonsson Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Terminated | G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders NCT00253552 | OHSU Knight Cancer Institute | N/A |
| Completed | Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent NCT00521430 | Asan Medical Center | N/A |
| Withdrawn | Collecting and Storing Blood Samples From Patients With Cancer NCT00900120 | University of Medicine and Dentistry of New Jersey | — |
| Completed | T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-I NCT00080925 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Terminated | Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral NCT00052884 | Eastern Cooperative Oncology Group | Phase 1 |
| Completed | Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Ste NCT00534118 | Roswell Park Cancer Institute | N/A |
| Terminated | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant NCT00369291 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma NCT00937183 | Jan Walewski | N/A |
| Completed | Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem NCT00248430 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer NCT00070382 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Completed | Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma NCT00432458 | Mayo Clinic | Phase 3 |
| Completed | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation NCT00064311 | National Institutes of Health Clinical Center (CC) | Phase 1 / Phase 2 |
| Completed | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematol NCT00089037 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Mal NCT00068523 | Case Comprehensive Cancer Center | N/A |
| Completed | Epoetin Alfa in Treating Anemia in Patients With Solid Tumors NCT00058331 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy NCT00066599 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myelo NCT00416897 | University of Glasgow | Phase 3 |
| Completed | Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant fo NCT00265837 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 3 |
| Completed | Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma NCT00060203 | Case Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma NCT00635154 | Mayo Clinic | Phase 2 |
| Completed | Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma NCT00049673 | NCIC Clinical Trials Group | Phase 3 |
| Completed | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer NCT00304018 | University of California, San Francisco | Phase 1 |
| Completed | Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00049374 | University of Maryland, Baltimore | Phase 2 |
| Completed | Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoi NCT00255710 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Prim NCT00089167 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologi NCT00054236 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma NCT00033332 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Pyroxamide in Treating Patients With Advanced Cancer NCT00042900 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Terminated | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer NCT00062231 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Completed | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients NCT00082654 | Fred Hutchinson Cancer Center | N/A |
| Completed | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer NCT00036790 | University of Wisconsin, Madison | Phase 1 |
| Completed | NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders NCT00053989 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multipl NCT00045136 | Poniard Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00022607 | California Cancer Consortium | Phase 2 |
| Withdrawn | Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer NCT00301912 | University of California, San Francisco | Phase 2 |
| Unknown | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiat NCT00036712 | Medical College of Wisconsin | Phase 2 |
| Completed | Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Mult NCT00046852 | University of Maryland, Baltimore | Phase 1 / Phase 2 |
| Completed | Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma NCT00014508 | Eastern Cooperative Oncology Group | Phase 2 |
| Active Not Recruiting | Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders NCT00544115 | City of Hope Medical Center | Phase 2 |
| Completed | Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma NCT00616720 | Mayo Clinic | Phase 2 |
| Completed | Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With NCT00027560 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or M NCT00237627 | UNC Lineberger Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00022282 | AEterna Zentaris | Phase 2 |
| Unknown | Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma NCT00028886 | Commissie Voor Klinisch Toegepast Onderzoek | Phase 3 |
| Completed | MS-275 in Treating Patients With Hematologic Cancer NCT00015925 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Terminated | Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Mul NCT00017069 | CTI BioPharma | Phase 2 |
| Terminated | Arsenic Trioxide in Treating Patients With Multiple Myeloma NCT00017433 | CTI BioPharma | Phase 2 |
| Completed | Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma NCT00017602 | Genta Incorporated | Phase 3 |
| Completed | Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High- NCT00014482 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Follow NCT00005946 | University of Maryland, Baltimore | Phase 1 |
| Completed | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Tre NCT00006348 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma NCT00006219 | Mayo Clinic | Phase 2 |
| Completed | Tipifarnib in Treating Patients With Advanced Hematologic Cancer NCT00005967 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon NCT00005987 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma NCT00008268 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | Beta Alethine in Treating Patients With Myeloma NCT00006466 | LifeTime Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Pa NCT00008229 | Fred Hutchinson Cancer Center | Phase 3 |
| Completed | Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple NCT00008242 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple M NCT00006890 | NCIC Clinical Trials Group | Phase 2 |
| Completed | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, NCT00010283 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating P NCT00365287 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Completed | Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma NCT00006021 | University of Miami | Phase 1 / Phase 2 |
| Completed | SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma NCT00006013 | Fox Chase Cancer Center | Phase 2 |
| Completed | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA NCT00006379 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin' NCT00006019 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | PS-341 in Treating Patients With Hematologic Cancer NCT00006098 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter NCT00006083 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Unknown | Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma NCT00014339 | Medsearch | Phase 3 |
| Completed | Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in P NCT00005606 | Northwestern University | Phase 2 |
| Completed | Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone M NCT00716911 | City of Hope Medical Center | N/A |
| Completed | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Pre NCT00005634 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer NCT00004132 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Pati NCT00006350 | University of Maryland, Baltimore | Phase 2 |
| Completed | Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Unde NCT00602706 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00005854 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00006042 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer NCT00004258 | Indiana University School of Medicine | Phase 1 |
| Terminated | 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment NCT00004239 | Alliance for Clinical Trials in Oncology | Phase 1 |
| Completed | St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer NCT00005805 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Completed | Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hemato NCT00044954 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer NCT00006225 | Northwestern University | Phase 1 / Phase 2 |
| Completed | PS-341 in Treating Patients With Advanced Cancer NCT00006362 | Mayo Clinic | Phase 1 |
| Completed | Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic NCT00612716 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leuk NCT00004181 | Northwestern University | Phase 2 |
| Unknown | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma NCT00004903 | Robert H. Lurie Cancer Center | Phase 2 |
| Completed | Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00004904 | Northwestern University | Phase 1 |
| Terminated | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer NCT00290628 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00005804 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma NCT00004165 | Northwestern University | Phase 3 |
| Completed | Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00004232 | Northwestern University | Phase 1 |
| Completed | O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma NCT00004072 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma NCT00021359 | Fox Chase Cancer Center | Phase 2 |
| Completed | Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Sy NCT00007995 | Herbert Irving Comprehensive Cancer Center | Phase 2 |
| Terminated | Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded NCT00006220 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Completed | Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treati NCT00004158 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologi NCT00005092 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multip NCT00004088 | City of Hope Medical Center | Phase 2 |
| Completed | 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis NCT00003853 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma NCT00003401 | University of Maryland, Baltimore | Phase 2 |
| Completed | Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer NCT00296023 | University of California, San Francisco | N/A |
| Completed | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy NCT00003600 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder NCT00004058 | University of Medicine and Dentistry of New Jersey | Phase 1 |
| Completed | High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amylo NCT00003353 | Eastern Cooperative Oncology Group | Phase 2 |
| Completed | Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients Wit NCT00004145 | University of Chicago | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Multiple Myeloma NCT00003493 | The Cleveland Clinic | Phase 2 |
| Completed | Rituximab in Treating Patients With Multiple Myeloma NCT00003554 | The Cleveland Clinic | Phase 2 |
| Completed | Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma NCT00003490 | The Cleveland Clinic | Phase 2 |
| Completed | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00003398 | University of Maryland, Baltimore | Phase 4 |
| Completed | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00003396 | University of Maryland, Baltimore | Phase 2 |
| Completed | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma NCT00003399 | University of Maryland, Baltimore | Phase 2 |
| Completed | Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer NCT00003451 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transp NCT00003887 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Pat NCT00003572 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transpla NCT00003153 | Eastern Cooperative Oncology Group | Phase 2 |
| Completed | Treatment for Chronic Pain in Patients With Advanced Cancer NCT00003687 | NCIC Clinical Trials Group | Phase 3 |
| Withdrawn | Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Mu NCT00004040 | Hoag Memorial Hospital Presbyterian | Phase 2 |
| Completed | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With C NCT00003408 | Cancer Treatment Centers of America | Phase 2 |
| Completed | Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00003962 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Unknown | Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treati NCT00008307 | Herbert Irving Comprehensive Cancer Center | Phase 2 |
| Completed | Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer NCT00003395 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00003960 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Unknown | Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma NCT00003603 | Riverside Haematology Group | Phase 3 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced Cancer NCT00003331 | NYU Langone Health | Phase 1 |
| Completed | Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma NCT00004902 | Northwestern University | Phase 2 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer NCT00003082 | University of Arizona | Phase 1 |
| Completed | Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transpla NCT00003195 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma a NCT00003341 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Completed | Interleukin-12 in Treating Patients With Multiple Myeloma NCT00003149 | Eastern Cooperative Oncology Group | Phase 2 |
| Unknown | Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, NCT00003885 | Our Lady of Mercy Medical Center | Phase 2 |
| Completed | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients NCT00003146 | Fred Hutchinson Cancer Center | Phase 2 |
| Unknown | Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer NCT00004036 | The Cleveland Clinic | Phase 1 |
| Completed | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood C NCT00003805 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors NCT00003107 | Indiana University School of Medicine | Phase 1 |
| Completed | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory NCT00003406 | Cancer Treatment Centers of America | Phase 1 / Phase 2 |
| Completed | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologi NCT00003270 | Roswell Park Cancer Institute | Phase 2 |
| Unknown | Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers NCT00003163 | Medical College of Wisconsin | Phase 2 |
| Terminated | Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation NCT00005641 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Mye NCT00002878 | Eastern Cooperative Oncology Group | Phase 3 |
| Completed | Decitabine in Treating Patients With Melanoma or Other Advanced Cancer NCT00002980 | California Cancer Consortium | Phase 1 |
| Completed | High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00003116 | Case Comprehensive Cancer Center | Phase 2 |
| Unknown | Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patie NCT00002989 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Unknown | Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplas NCT00008164 | Herbert Irving Comprehensive Cancer Center | Phase 2 |
| Completed | Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma NCT00002907 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma NCT00006232 | West of Scotland Lymphoma Group | Phase 3 |
| Terminated | Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer NCT00008216 | Columbia University | — |
| Completed | Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stag NCT00003007 | University of Tennessee | Phase 2 |
| Terminated | Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Mar NCT00005852 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis NCT00002810 | Temple University | Phase 2 |
| Completed | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer NCT00002742 | Aronex Pharmaceuticals | Phase 3 |
| Completed | Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss NCT00003077 | Alliance for Clinical Trials in Oncology | Phase 1 / Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Multiple Myeloma NCT00002678 | NCIC Clinical Trials Group | Phase 3 |
| Completed | SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patient NCT00002657 | SWOG Cancer Research Network | Phase 2 |
| Completed | Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease NCT00002652 | University of Arkansas | Phase 2 |
| Completed | High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malig NCT00002818 | Virginia Commonwealth University | Phase 1 |
| Unknown | Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantati NCT00002599 | Medical Research Council | Phase 3 |
| Completed | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hod NCT00002552 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Unknown | Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multi NCT00002653 | Medical Research Council | Phase 3 |
| Completed | High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients Wit NCT00002630 | Mayo Clinic | Phase 2 |
| Completed | Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer NCT00002504 | Hoag Memorial Hospital Presbyterian | Phase 2 |
| Completed | Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic NCT00002502 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transp NCT00060255 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma NCT00900055 | OHSU Knight Cancer Institute | — |
| Withdrawn | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Bloo NCT01101412 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Unknown | SU006668 in Treating Patients With Advanced Solid Tumors NCT00024063 | Jonsson Comprehensive Cancer Center | Phase 1 |